Sign In
Buy CCXI
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
11:25am, Wednesday, 27'th May 2020Wells Fargo Initiates Coverage On ChemoCentryx with Overweight Rating, Announces Price Target of $79
10:56am, Wednesday, 27'th May 2020Profiting From The Consensus Stock Holdings Of Five Hedge Funds
04:29pm, Sunday, 24'th May 2020
This is a copycat trading strategy based on the quarterly 13F filings of five hedge funds. The model holds the top 20 consensus picks from a group of five hedge
The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
12:00am, Friday, 22'nd May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 21)
ADC Therapeutics SA (NYSE:...
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
Deciphera's GIST Approval, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:CCXI)
08:21am, Tuesday, 19'th May 2020
Deciphera's Qinlock received FDA approval for GIST cancers. Chemocentryx reports below par kidney data. Moderna is up on positive COVID-19 data news.
Canaccord Genuity Maintains Buy on ChemoCentryx, Lowers Price Target to $58
12:00am, Tuesday, 19'th May 2020EN DIRECT DES MARCHES : Total, Vinci, Airbus, ADP, Seb, Neovacs, Compass, ThyssenKrupp, JC Penney...
12:50pm, Monday, 18'th May 2020
ChemoCentryx, Inc., (CCXI) and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced topline data from a forty-six (46) patient Phase II dose-ranging trial in the orphan kidney disorder,
